A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine

Clinical trial NCT06147622 · COMPLETED

Trial details

NCT number: NCT06147622
Sponsor: Kinnov Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2024-04-23
Primary completion: 2024-07-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.